We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,224.20
Bid: 1,224.00
Ask: 1,224.40
Change: 8.20 (0.67%)
Spread: 0.40 (0.03%)
Open: 1,202.20
High: 1,236.80
Low: 1,202.20
Yest. Close: 1,216.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

FTSE 100 Movers: Burberry grows internationally

Burberry is leading the market higher after strong third quarter figures. Revenue grew by 30% in the third quarter and full year profit is expected to be at the top end of market expectations. The growth is coming from around the world. Oil services provider Petrofac has won a $1.2bn oil field d

18 Jan 11 13:15

Broker tips: SABMiller, Glaxo, Chemring

Nomura expects to see a short-term bounce in SABMiller's share price following the volume improvement in the third quarter, but the broker remains cautious about the brewer's ability to achieve a return to historical growth rates. The owner of Peroni and Grolsch said that its third quarter volumes

18 Jan 11 12:45

TechMARK movers: Optos grows revenues by 10%

Shares in Optos have fallen back even though there was a 10% year-on-year increase in revenues in the three months to December 2010. The medical retinal imaging company reported a fall in operating lease revenues but these were more than made up for by higher outright sales and sales under finance

18 Jan 11 12:33

Broker snap: Glaxo to shrug off legal tribulations

GlaxoSmithKline's (GSK) latest legal charge has not persuaded financial services firms Matrix to change its 'buy' rating on the stock as the broker believes that the pharmaceuticals giant will emerge from the latest lawsuits in a stronger position. On Monday GSK announced a new legal charge of £2.2

18 Jan 11 12:06

Tuesday newspaper round-up: BRICs, Inflation, GlaxoSmithKline...

Goldman Sachs has issued a short-term alert on China and India as inflation rears its ugly head, advising clients to rotate into Wall Street and Old World bourses as a safer bet over coming months. "We're not as tactically positive on the BRICs as we have been," said Tim Moe, the bank's chief Asia-

18 Jan 11 06:33

Sector movers: Smiths give industrials a lift

The general industrials sector was given a boost on Monday by Smiths Group. Shares in Smiths Group were soaring Monday after the maker of medical devices and airport scanners said after the close of trading on Friday that it had rejected a £2.45bn approach for its biggest division Smiths Medical.

17 Jan 11 15:57

Glaxo takes £2.2bn legal charge for fourth quarter

GlaxoSmithKline (GSK) will take a legal charge of £2.2bn for the fourth quarter of 2010, mostly linked to an investigation into US sales and promotional practices and for product liability cases regarding diabetes drug Avandia. The British company had already flagged a charge of £1.57bn for the sec

17 Jan 11 14:59

Glaxo snaps up Maxinutrition for £162m

GlaxoSmithKline is paying Darwin Private Equity £162m in cash for protein drinks firm Maxinutrition. The British drugs giant, which already owns the Lucozade sports drink franchise, will own brands like Maximuscle used by weight-trainers. Maxinutrition is Europe's top sports nutrition company by

13 Dec 10 14:07

Glaxo in Chinese bolt-on acquisition

Anglo-American drugs giant GlaxoSmithKline is to increase its exposure to the fast growing Chinese pharmaceuticals market. Glaxo is paying around $70m in cash for MeiRui, a company with a strong portfolio of urology and allergy products, including Prostat for benign prostatic hyperplasia and Shenit

7 Dec 10 08:02

London afternoon: ECB inaction deflates market

The absence of any mention of plans to launch a bond purchase in the European Central Bank (ECB) press conference this afternoon has taken some of the glow off equities. "We expect the governments to follow what they are committed to, they all have their adjustment and stabilisation programmes," E

2 Dec 10 14:28

Glaxo ups Theravance stake by $129m

GlaxoSmithKline has increased its stake in American lung drug firm Theravance to 19% after picking up 5.75m shares in a private placing today. The UK drugs giant is paying $22.5 a share for the holding, valuing the deal at $129.4m and taking its total interest in its respiratory drug partner to 15.

29 Nov 10 11:10

Thursday newspaper round-up: Ireland, General Motors, GlaxoSmithKline

The Irish Government finally signalled yesterday that it may bow to international pressure and accept a multibillion-pound bailout, amid divisions in the Commons over whether Britain should contribute. While the details of any package may be several days away, there were growing signs that Britain c

18 Nov 10 06:31

FTSE 100 movers: Ex-dividend declines

Footsie's fallers are dominated by shares that are going ex-dividend. Marks & Spencer, Carnival, Sainsbury and Vodafone have all gone ex-dividend today. Retailer Marks & Spencer is paying an interim dividend of 6.2p a share but the share price has fallen by nearly double the amount of the dividen

17 Nov 10 13:38

TechMARK movers: Vodafone goes ex-dividend

TechMARK's decline will undoubtedly have been influenced by Vodafone going ex-dividend. Mobile phone networks operator Vodafone is paying an interim dividend of 2.85p a share, which is similar to the size of the fall in the share price. Vodafone is the biggest company in TechMARK Positive news fr

17 Nov 10 13:38

FTSE 100 movers: ARM recovers

Footsie is moving ahead today thanks to a wide range of companies. Chip designer ARM is clawing back some of its recent losses. Vodafone has spent another £21.7m on buying back shares. That takes the total spent since 16 September to £464.5m. The share price has risen by more than 8% in the past

28 Oct 10 12:57

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.